logo
ResearchBunny Logo
Broadly neutralizing antibodies against COVID-19

Biology

Broadly neutralizing antibodies against COVID-19

D. Zhou, J. Ren, et al.

Explore the cutting-edge research by Daming Zhou and colleagues on the challenges posed by SARS-CoV-2 mutations and the promise of broadly neutralizing monoclonal antibodies to maintain therapeutic efficacy. Discover how these innovative treatments can play a crucial role in combating COVID-19 variants.

00:00
00:00
Playback language: English
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in millions of infections and deaths. Human monoclonal antibodies (mAbs) offer an effective treatment option. However, the virus's rapid mutation leads to immune escape from most neutralizing mAbs, including approved therapeutics. This review focuses on four types of broadly neutralizing mAbs targeting the spike protein: those targeting the receptor-binding domain (RBD), subdomain 1 (SD1), stem helix, or fusion peptide. Understanding how these mAbs maintain potency against various variants is crucial for developing future therapeutics and vaccines.
Publisher
Current Opinion in Virology
Published On
Apr 26, 2023
Authors
Daming Zhou, Jingshan Ren, Elizabeth E Fry, David I Stuart, Kuan-Ying Arthur Huang, Chealex Ma
Tags
COVID-19
SARS-CoV-2
monoclonal antibodies
neutralizing antibodies
therapeutics
spike protein
immune escape

Related Publications

Explore these studies to deepen your understanding of the subject.

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Medicine and Health

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants

M. Belik, P. Jalkanen, et al.

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Medicine and Health

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection

L. M. Coria, J. M. Rodriguez, et al.

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
Medicine and Health

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination

X. Chi, Y. Guo, et al.

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
Medicine and Health

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

L. Peng, Y. Hu, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny